Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Oktober 2015 16:41 ET | Quelle: Sandoz Canada

Sandoz Canada launches PrSandoz(R) Solifenacin on the Canadian market for the treatment of urinary urgency, frequency and incontinence

Version française BOUCHERVILLE, QC, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of a new drug on the Canadian market, PrSandoz® Solifenacin (solifenacin...
25. September 2015 09:15 ET | Quelle: Sandoz Canada

Sandoz Canada Celebrates Its 10th Anniversary!

Lire la version française BOUCHERVILLE, Quebec, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. celebrated its 10th anniversary on September 19 this year with a colourful event in...
02. September 2015 16:11 ET | Quelle: Sandoz Canada

Health Canada Approves New Indications for PrOmnitrope(R) (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)

Click here for the French version. BOUCHERVILLE, Quebec, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc., a Novartis company, has received approval from Health Canada for a number of...
20. August 2015 16:42 ET | Quelle: Sandoz Canada

Sandoz Canada launches PrAmiodarone Syringe for the treatment of several heart rhythm disorders

BOUCHERVILLE, Quebec, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Version française Sandoz Canada Inc., a Novartis company, continues to innovate with the launch of PrAmiodarone Syringe (PrAmiodarone...

Vorherige Seite